Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases

Medical Care

Volumn 51, Issue 8 SUPPL.3, 2013, Pages

  Raebel, Marsha A ^a,b   Schmittdiel, Julie ^c   Karter, Andrew J ^c   Konieczny, Jennifer L ^b   Steiner, John F ^a,d  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c DIVISION OF RESEARCH   (United States)

^d UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

administrative; computerized medical record systems; database; electronic health record; medication adherence; medication discontinuation; medication persistence; refill compliance; refill persistence

Indexed keywords

ARTICLE; CONCEPTUAL FRAMEWORK; DATA BASE; ELECTRONIC MEDICAL RECORD; ELECTRONIC PRESCRIBING; HUMAN; MEDICAL RESEARCH; MEDICATION COMPLIANCE; NOMENCLATURE; PHARMACY; PRIORITY JOURNAL;

DATABASES, FACTUAL; ELECTRONIC HEALTH RECORDS; HEALTH SERVICES RESEARCH; HUMANS; INSURANCE CLAIM REVIEW; MEDICATION ADHERENCE; MULTICENTER STUDIES AS TOPIC; PHARMACEUTICAL SERVICES; TERMINOLOGY AS TOPIC;

EID: 84879885497     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e31829b1d2a     Document Type: Article

References (51)

1. Steiner JF. Rethinking adherence. Ann Intern Med. 2012;157:580-585.
2. McGinnis B, Olson KL, Magid D, et al. Factors related to adherence to statin therapy. Ann Pharmacother. 2007;41:1805-1811. (Pubitemid 350044342)
3. Batal HA, Krantz MJ, Dale RA, et al. Impact of prescription size on statin adherence and cholesterol levels. BMG Health Serv Res. 2007;7:175.
4. Briesacher BA, Andrade SE, Fouayzi H, et al. Comparison of drug adherence rates among patients with seven different medical conditions. . Pharmacotherapy. 2008;28:437-443. (Pubitemid 351466455)
5. Chan DC, Shrank WH, Cutler D, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010;48:196-202.
6. Karter AJ, Parker MM, Moffet HH, et al. New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res. 2009;44:1640-1661.
7. Kane S, Shaya F. Medication non-adherence is associated with increased medical health care costs. Dig Dis Sci. 2008;53:1020-1024. (Pubitemid 351379831)
8. Ho PM, Magid DJ, Masoudi FA, et al. Adherence to cardioprotective medications and mortality among patients with diabetes and ischemic heart disease. BMC Cardiovasc Disord. 2006;6:48.
9. Kramer JM, Hammill B, Anstrom KJ, et al. National evaluation of adherence to beta-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance. Am Heart J. 2006;152:454e1-454e8.
10. Raebel MA, Carroll NM, Ellis JL, et al. Importance of early nonadherence in estimations of medication adherence. Ann Pharmacother. 2011;45:1053-1060.
11. Siegel D, Lopez J, Meier J. Antihypertensive medication adherence in the Department of Veterans Affairs. Am J Med. 2007;120:26-32. (Pubitemid 46026987)
12. Shah NR, Hirsch AG, Zacker C, et al. Predictors of first-fill adherence for patients with hypertension. Am J Hypertens. 2009;22:392-396.
13. Shah NR, Hirsch AG, Zacker C, et al. Factors associated with first-fill adherence rates for diabetic medications: a cohort study. J Gen Intern Med. 2009;24:233-237.
14. Carroll NM, Ellis JL, Luckett C, et al. Feasibility of determining medication adherence from electronic health record medications orders. J Am Med Inform Assoc. 2011;18:717-720.
15. Fischer MA, Stedman MR, Lii J, et al. Primary medication nonadherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med. 2010;25:284-290.
16. Karter AJ, Parker MM, Adams AS, et al. Primary non-adherence to prescribed medications. J Gen Intern Med. 2010;25:763.
17. Raebel MA, Ellis JL, Carroll NM, et al. Characteristics of patients with primary nonadherence to medications for hypertension, diabetes, and lipid disorders. J Gen Intern Med. 2012;27:57-64.
18. Andrade SE, Kahler KH, Frech F, et al. Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf. 2006;15:565-574. (Pubitemid 44336271)
19. Caetano PA, Lain JMC, Morgan SG. Toward a standard definition and measurement of persistence with drug therapy: examples from research on statin and antihypertensive utilization. Clin Ther. 2006;28:1411-1424. (Pubitemid 44585292)
20. Cramer JA, Roy A, Burrell A, et al. Medication compliance and persistence: terminology and definitions. Value Health. 2008;11:44-47. (Pubitemid 351160875)
21. World Health Organization. Adherence to long-term therapies: Evidence for action. Available at: http://www.who.int/chp/knowledge/publications/adherence- report/en/. 2003. Accessed November 14, 2012.
22. Phillipson TJ, Mozaffari E, Maclean JR. Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndrome. Am J Manag Care. 2010;16:290-297.
23. Schneeweiss S, Patrick AR, Maclure M, et al. Adherence to beta-blocker therapy under drug cost-sharing in patients with and without acute myocardial infarction. Am J Manag Care. 2007;13:445-452. (Pubitemid 47301271)
24. Yu AP, Yu YF, Nichol MB, et al. Delay in filling the initial prescription for a statin: a potential early indicator of medication nonpersistence. Clin Ther. 2008;30:761-774. (Pubitemid 351680500)
25. Vrijens B, De Geest S, Hughes DA, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691-705.
26. Briesacher BA, Andrade SE, Harrold LR, et al. Adherence and occurrence of fractures after switching to once-monthly oral bisphophonates. Pharmacoepidemiol Drug Saf. 2010;19:1233-1240.
27. Huybrechts KF, Ishak KJ, Caro JJ. Assessment of compliance with osteoporosis treatment and its consequences in a managed care population. Bone. 2006;38:922-928. (Pubitemid 44498580)
28. Deambrosis P, Saramin C, Terrazzani G, et al. Evaluation of the prescription and utilization patterns of statins in an Italian local health unit during the period 1994-2003. Eur J Clin Pharmacol. 2007;63: 197-203. (Pubitemid 46147062)
29. Hertz RP, Unger AN, Lustik MB. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employersponsored health insurance. Clin Ther. 2005;27:1064-1073. (Pubitemid 41262464)
30. Carnahan RM, Lund BC, Chrischilles EA, et al. Consistency of antidepressant and chronic nonpsychiatric medication use in a high-risk clinical population. Res Soc Admin Pharm. 2008;4:367-374.
31. Christensen L, Sasane R, Hodgkins P, et al. Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population. Curr Med Res Opin. 2010;26:977-989.
32. Erkens JA, Panneman MMJ, Klungel OH, et al. Differences in antihypertensive drug persistence associated with drug class and gender: a PHARMO study. Pharmacoepidemiol Drug Saf. 2005;14:795-803. (Pubitemid 41684472)
33. Gold DT, Martin BC, Frytak JR, et al. A claims database analysis of persistence with alendronate therapy and fracture risk in postmenopausal women with osteoporosis. CMRO. 2007;23:585-594. (Pubitemid 46456906)
34. Yeaw J, Benner JS, Walt JG, et al. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728-740.
35. van Wijka BLG, Shrank WH, Klungela OH, et al. A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens. 2008;26:145-153. (Pubitemid 350294860)
36. Barron TI, Connolly RM, Bennett K, et al. Early discontinuation of tamoxifen: a lesson for oncologists. Cancer. 2007;109:832-839. (Pubitemid 46333524)
37. Boccuzzi SJ,Wogen J, Fox J, et al. Utilization of oral hypoglycemic agents in a drug-insured US population. Diabetes Care. 2001;24:1411-1415. (Pubitemid 33716429)
38. El-Serag H, Fitzgerald S, Richardson P. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol. 2009;104:2167.
39. Kalsekar ID, Madhavan SS, Amonkar MM, et al. Impact of depression on utilization patterns of oral hypoglycemic agents in patients newly diagnosed with type 2 diabetes mellitus: a retrospective cohort analysis. Clin Ther. 2006;28:306-318.
40. Hess LM, Raebel MA, Conner DA, et al. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-1288. (Pubitemid 44204957)
41. Nau DP. Proportion of days covered (PDC) as a preferred method of measuring medication adherence. 2011. Available at: http://www.pqaal liance.org/images/uploads/files/PQA%20PDC%20vs%20%20MPR.pdf. Accessed February 11, 2013.
42. Karve S, Cleves MA, Helm M, et al. An empirical basis for standardizing adherence measures derived from administrative claims data among diabetic patients. Med Care. 2008;46:1125-1133.
43. Bryson CL, Au DH, Young B, et al. A refill adherence algorithm for multiple short intervals to estimate refill compliance (ReComp). Med Care. 2008;45:497-503.
44. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-461. (Pubitemid 34787476)
45. Leslie RS. Using arrays to calculate medication utilization. SAS Paper 043-2007. Available at: http://www2.sas.com/proceedings/forum2007/043-2007.pdf. Accessed April 26, 2012.
46. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol. 1997;50:105-116. (Pubitemid 27089212)
47. Peterson AM, Nau DP, Cramer JA, et al. A checklist for medication compliance and persistence studies using retrospective databases. Value Health. 2007;10:3-12. (Pubitemid 46161090)
48. Karve S, Cleves MA, Helm M, et al. Prospective validation of eight different adherence measures for use with administrative claims data among patients with schizophrenia. Value Health. 2009;12:989-995.
49. Hansen RA, Kim MM, Song L, et al. Comparison of methods to assess medication adherence and classify nonadherence. Ann Pharmacother. 2009;43:413-422.
50. Pharmacy Quality Alliance. PQA measures used by CMS in the STAR ratings. 2012. Available at: http://pqaalliance.org/measures/cms.asp. Accessed February 11, 2013.
51. National Quality Forum. Available at: http://www.qualityforum.org/home. aspx. Accessed February 11, 2013.